ODDO Meriten Asset Management Form 8.3 - CLINIGEN GROUP (6937R)
September 25 2017 - 4:00AM
UK Regulatory
TIDMCLIN
RNS Number : 6937R
ODDO Meriten Asset Management
25 September 2017
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: ODDO MERITEN ASSET MANAGEMENT SAS
---------------------------------------------------------------------------------- ----------------------------------
(b) Owner or controller of interests and short positions disclosed, if different
from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the
trustee(s),
settlor and beneficiaries must be named.
---------------------------------------------------------------------------------- ----------------------------------
(c) Name of offeror/offeree in relation to whose relevant securities this form CLINIGEN GROUP
relates:
Use a separate form for each offeror/offeree
---------------------------------------------------------------------------------- ----------------------------------
(d) If an exempt fund manager connected with an offeror/offeree, state this and
specify identity
of offeror/offeree:
---------------------------------------------------------------------------------- ----------------------------------
(e) Date position held/dealing undertaken: 22/09/2017
For an opening position disclosure, state the latest practicable date prior to
the disclosure
---------------------------------------------------------------------------------- ----------------------------------
(f) In addition to the company in 1(c) above, is the discloser making disclosures NO
in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
---------------------------------------------------------------------------------- ----------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: Common stock
---------------------------------------------------------------------------------- ----------------------------------
Interests Short positions
---------------------------------------------------------------------------------- -------------- ------------------
Number % Number %
---------------------------------------------------------------------------------- --------- --- --------- -------
(1) Relevant securities owned and/or controlled: 342 225 -0.30%
-------------------------------------------------------------------------------------------------- --------- -------
(2) Cash-settled derivatives:
---------------------------------------------------------------------------------- --------- --- --------- -------
(3) Stock-settled derivatives (including options) and agreements to
purchase/sell:
---------------------------------------------------------------------------------- --------- --- --------- -------
TOTAL: 342 225 -0.30%
-------------------------------------------------------------------------------------------------- --------- -------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
----------------------------------------------------------------------------
Details, including nature of the rights concerned and relevant percentages:
----------------------------------------------------------------------------
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
--------------------------- -------------- --------------------- ---------------
Ordinary Sale (22/09) 6 101 1057.358 GBp
Ordinary Sale (21/09) 25 715 1046.714 GBp
Ordinary Sale (21/09) 9 809 1050.043 GBp
Ordinary Sale (21/09) 70 875 1035.90 GBp
Ordinary Sale (21/09) 8 075 1051.456 GBp
Ordinary Sale (20/09) 10 125 1030.89 GBp
Ordinary Sale (19/09) 405 1019 GBp
Ordinary Sale (18/09) 3 916 1039.529 GBp
Ordinary Sale (18/09) 810 1039.20 GBp
Ordinary Sale (15/09) 351 1041.36 GBp
Ordinary Sale (15/09) 818 1044.023 GBp
Ordinary Sale (15/09) 13 217 1026.80 GBp
Ordinary Sale (14/09) 21 133 1051.089 GBp
Ordinary Sale (13/09) 19000 1089.38 GBp
Ordinary Sale (13/09) 10 125 1097.946 GBp
Ordinary Sale (13/09) 141 750 1083.53 GBp
Ordinary
Ordinary
--------------------------- -------------- --------------------- ---------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
------------------------- -------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
------------- ------------- ------------- ------------- -------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
----------------------- -------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
--------------------------- ------------------------------- -------- -------------------------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
---------------------------------------------------------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
-----------------------------------------------------------------------------------------------
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? NO
---------------------------------------------------- ---
Date of disclosure: 25/09/2017
-------------------- ----------------------------
Contact name: Corinne LEHR / Sophie SABRI
+33 1 44 51 81 38 / 85 20
-------------------- ----------------------------
Tanguy GOSSEIN
+33 1 44 51 87 51
-------------------- ----------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service and must also be emailed to the
Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market
Surveillance Unit is available for consultation in relation to the
Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RETOKPDPFBKKBCB
(END) Dow Jones Newswires
September 25, 2017 05:00 ET (09:00 GMT)
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clinigen (LSE:CLIN)
Historical Stock Chart
From Jul 2023 to Jul 2024